Untitled Document Today's Rundown Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug Private equity giant Blackstone buys Clarus in biopharma push DDF 2018: Diversity can fuel company growth outside of a strong profit case This year’s Fierce 15 winners on burgeoning biotech investment and the decade ahead Sarepta sees muscle function gains with DMD gene therapy DDF 2018: Approaching accelerated approvals in multiple markets BIO’s ultimatum to members: Get serious about gender diversity or face our fury Featured Story | | | Thursday, October 4, 2018 Johnson & Johnson has paid $175 million upfront for the global rights to Arrowhead’s phase 1/2 RNAi hepatitis B drug. The outlay, plus $1.6 billion in milestones, has bought J&J a drug that slashed levels of hepatitis B virus in a small, early-phase assessment. |
|
|
| This week's sponsor is the Fierce Innovation Awards – Life Sciences Edition. | | | |
Top Stories Thursday, October 4, 2018 Blackstone has struck a deal to buy Clarus. The takeover will move private equity giant Blackstone deeper into biopharma, where it plans to use its financial might to fund R&D programs that have outgrown the means of traditional venture capital firms. Wednesday, October 3, 2018 To best address diversity, or a lack thereof, companies need to build formal, proactive systems within their organizations—not only to gather a wide array of perspectives but also to help new employees feel invested in the company more quickly and to help them do their best work. Wednesday, October 3, 2018 This year’s class of Fierce 15 landed during a banner year for venture capital investment in biotech. We asked them if they thought the trend would continue or if the bubble would burst. Thursday, October 4, 2018 Preliminary signs of improved muscle function have been seen in Sarepta's Duchenne muscular dystrophy gene therapy trial. Thursday, October 4, 2018 Other regions are catching up to the U.S. in terms of accelerated approval pathways, but companies will need to take a more holistic approach to succeed on the global scale. Thursday, October 4, 2018 After an unofficial party at this year’s BIO convention stirred up controversy, the biotech industry’s largest trade association is tightening the screws on its members to step up gender diversity—and show a little respect at their parties—or else. | This week's sponsor is IQVIA. | | | Congratulations Fierce 15
We admire and recognize your passion to address unmet medical needs and we support your vision to advance modern medicine. You Are Driving Innovation Forward. Let's talk. |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: RWS Life Sciences Examine the linguistic and cultural considerations of global eCOA and BYOD. Sponsored by: Amazon Web Services Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Docusign Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin? Sponsored by: Veeva A top 20 pharma and growing biotech re-engineer regulatory processes. Sponsored by: Sciformix Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be! Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: AWS and Tableau Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children. Sponsored by: AWS and Reltio Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS. Presented by: AWS and Druva Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Drug Development Boot Camp® 2018 – Registration closes 30 October - Register Now! November 14-15, 2018 | Boston, MA | Registration closes on the 30 of October 2018 due to the need for participants to complete pre-Boot Camp preparations. Register now and start preparing for this intensive training in drug development. AI World Conference and Expo 2018 Monday, December 3, 2018 | 10/5/18 – Early Deadline PepTalk: The Protein Science Week January 14, 2019 | October 19, 2018 – Early Deadline
Compliance Certification Program at Seton Hall Law October 8-11, 2018 | Newark, NJ BioImmersion: Biotech for the Non-Scientist October 16-18, 2018 | Chicago, IL Fierce Innovation Awards: Life Sciences Edition 2018 Welcome to the inaugural Neuromuscular Drug Development Summit October 29-31, 2018 | Boston, MA, USA FierceBiotech Executive Summit: London October 30, 2018 | Royal Society of Medicine Drug Development Immersion November 1-2, 2018 | Boston, MA European Healthcare Compliance Certification Program November 5-8, 2018 | Paris, France Understanding Commercialization Within Biopharma Nov 7-8, 2018 | Boston, MA Drug Development Immersion December 5-6, 2018 | San Diego, CA BioBasics: Biotech For The Non-Scientist December 5-6, 2018 | Boston, MA Understanding Drug Pricing and Reimbursement December 12, 2018 | Boston, MA | 